Template:Cholecystitis Antibiotics - Revision history

Danbot: Add pediatric dosing section

2026-03-20T13:20:37Z

Add pediatric dosing section

← Older revision		Revision as of 13:20, 20 March 2026
Line 19:		Line 19:
	*{{AntibioticDose\|disease=Acute calculous cholecystitis\|drug=Doripenem\|dose=500mg IV q8hrs\|context=Complicated}}		*{{AntibioticDose\|disease=Acute calculous cholecystitis\|drug=Doripenem\|dose=500mg IV q8hrs\|context=Complicated}}
	*{{AntibioticDose\|disease=Acute calculous cholecystitis\|drug=Meropenem\|dose=1g IV q8hrs\|context=Complicated}}		*{{AntibioticDose\|disease=Acute calculous cholecystitis\|drug=Meropenem\|dose=1g IV q8hrs\|context=Complicated}}

			====Pediatric====
			*{{AntibioticDose\|disease=Acute calculous cholecystitis\|drug=Ceftriaxone\|dose=50-75mg/kg IV daily (max 2g)\|context=Pediatric\|population=Pediatric}} + {{AntibioticDose\|disease=Acute calculous cholecystitis\|drug=Metronidazole\|dose=7.5mg/kg IV q8hrs (max 500mg)\|context=Pediatric\|population=Pediatric}} '''OR'''
			*{{AntibioticDose\|disease=Acute calculous cholecystitis\|drug=Piperacillin/Tazobactam\|dose=80-100mg/kg IV q6-8hrs (max 4.5g)\|context=Pediatric\|population=Pediatric}} '''OR'''
			*{{AntibioticDose\|disease=Acute calculous cholecystitis\|drug=Meropenem\|dose=20mg/kg IV q8hrs (max 1g)\|context=Pediatric Complicated\|population=Pediatric}}

Danbot: Fix disease parameter: Acute calculous cholecystitis (canonical name, Cholecystitis redirects there)

2026-03-19T23:13:56Z

Fix disease parameter: Acute calculous cholecystitis (canonical name, Cholecystitis redirects there)

Danbot: Add disease=Cholecystitis parameter to AntibioticDose calls - fixes aggregation page display issue

2026-03-19T23:12:42Z

Add disease=Cholecystitis parameter to AntibioticDose calls - fixes aggregation page display issue

Danbot: Convert to {{AntibioticDose}} for SMW antibiotic-disease linking

2026-03-19T22:48:53Z

Convert to {{AntibioticDose}} for SMW antibiotic-disease linking

← Older revision		Revision as of 22:48, 19 March 2026
Line 2:		Line 2:

	====Uncomplicated====		====Uncomplicated====
	''Pathogenicity of [[Enterococci]] remains unclear and specific coverage is not routinely suggested for community-acquired infections''<ref name=~~“WSES 2016”~~>Ansaloni L, et al. 2016 WSES guidelines on acute calculous cholecystitis. World Journal of Surgery. (2016) 11:25. DOI 10.1186/s13017-016-0082-5</ref>		''Pathogenicity of [[Enterococci]] remains unclear and specific coverage is not routinely suggested for community-acquired infections''<ref name="WSES 2016">Ansaloni L, et al. 2016 WSES guidelines on acute calculous cholecystitis. World Journal of Surgery. (2016) 11:25. DOI 10.1186/s13017-016-0082-5</ref>
	*[[Ertapenem]] 1g IV once daily OR		*{{AntibioticDose\|drug=Ertapenem\|dose=1g IV once daily\|context=Uncomplicated}} OR
	*[[Metronidazole]] 500mg IV q8hrs PLUS		*{{AntibioticDose\|drug=Metronidazole\|dose=500mg IV q8hrs\|context=Uncomplicated}} PLUS
	**[[Ciprofloxacin]] 400mg IV q12 hrs OR		**{{AntibioticDose\|drug=Ciprofloxacin\|dose=400mg IV q12 hrs\|context=Uncomplicated}} OR
	**[[Levofloxacin]] 750mg IV q24hrs OR		**{{AntibioticDose\|drug=Levofloxacin\|dose=750mg IV q24hrs\|context=Uncomplicated}} OR
	**[[Ceftriaxone]] 1g IV q24hrs		**{{AntibioticDose\|drug=Ceftriaxone\|dose=1g IV q24hrs\|context=Uncomplicated}}

	====Complicated or Healthcare Associated====		====Complicated or Healthcare Associated====
	''Examples of complication include severe [[sepsis]] or hemodynamic instability''		''Examples of complication include severe [[sepsis]] or hemodynamic instability''
	*[[Vancomycin]] 15-20mg/kg PLUS any of the following options		*{{AntibioticDose\|drug=Vancomycin\|dose=15-20mg/kg\|context=Complicated/Healthcare Associated}} PLUS any of the following options

	'''Options:'''		'''Options:'''
	*[[Metronidazole]] 500mg IV q8hrs PLUS [[Ciprofloxacin]] 400mg IV q12hrs		*{{AntibioticDose\|drug=Metronidazole\|dose=500mg IV q8hrs\|context=Complicated}} PLUS {{AntibioticDose\|drug=Ciprofloxacin\|dose=400mg IV q12hrs\|context=Complicated}}
	*[[Piperacillin/Tazobactam]] 4.5g IV q8hrs		*{{AntibioticDose\|drug=Piperacillin/Tazobactam\|dose=4.5g IV q8hrs\|context=Complicated}}
	*[[Imipenem/~~Cilastin]]~~ 500mg IV q6hrs		*{{AntibioticDose\|drug=Imipenem/Cilastatin\|dose=500mg IV q6hrs\|context=Complicated}}
	*[[Doripenem]] 500mg IV q8hrs		*{{AntibioticDose\|drug=Doripenem\|dose=500mg IV q8hrs\|context=Complicated}}
	*[[Meropenem]] 1g IV q8hrs		*{{AntibioticDose\|drug=Meropenem\|dose=1g IV q8hrs\|context=Complicated}}

Rossdonaldson1 at 03:56, 3 April 2019

2019-04-03T03:56:12Z

← Older revision		Revision as of 03:56, 3 April 2019
Line 2:		Line 2:

	====Uncomplicated====		====Uncomplicated====
	''Pathogenicity of [[Enterococci]] remains unclear and specific coverage is not routinely suggested for community-acquired infections''<ref>Ansaloni L, et al. 2016 WSES guidelines on acute calculous cholecystitis. World Journal of Surgery. (2016) 11:25. DOI 10.1186/s13017-016-0082-5</ref>		''Pathogenicity of [[Enterococci]] remains unclear and specific coverage is not routinely suggested for community-acquired infections''<ref name=“WSES 2016”>Ansaloni L, et al. 2016 WSES guidelines on acute calculous cholecystitis. World Journal of Surgery. (2016) 11:25. DOI 10.1186/s13017-016-0082-5</ref>
	*[[Ertapenem]] 1g IV once daily OR		*[[Ertapenem]] 1g IV once daily OR
	*[[Metronidazole]] 500mg IV q8hrs PLUS		*[[Metronidazole]] 500mg IV q8hrs PLUS

Rossdonaldson1 at 02:48, 3 April 2019

2019-04-03T02:48:47Z

← Older revision		Revision as of 02:48, 3 April 2019
Line 1:		Line 1:
	''Most often isolated organisms are [[Escherichia coli]], [[Klebsiella pneumonia]], and [[anaerobes]], especially [[Bacteroides fragilis]]''		''Most often isolated organisms are [[Escherichia coli]], [[Klebsiella pneumonia]], and [[anaerobes]], especially [[Bacteroides fragilis]]''

	====Uncomplicated ~~Cholecystitis~~====		====Uncomplicated====
	''Pathogenicity of [[Enterococci]] remains unclear and specific coverage is not routinely suggested for community-acquired infections''<ref>Ansaloni L, et al. 2016 WSES guidelines on acute calculous cholecystitis. World Journal of Surgery. (2016) 11:25. DOI 10.1186/s13017-016-0082-5</ref>		''Pathogenicity of [[Enterococci]] remains unclear and specific coverage is not routinely suggested for community-acquired infections''<ref>Ansaloni L, et al. 2016 WSES guidelines on acute calculous cholecystitis. World Journal of Surgery. (2016) 11:25. DOI 10.1186/s13017-016-0082-5</ref>
	*[[Ertapenem]] 1g IV once daily OR		*[[Ertapenem]] 1g IV once daily OR

Rossdonaldson1: /* Complicated */

2019-04-03T02:46:57Z

Complicated

← Older revision		Revision as of 02:46, 3 April 2019
Line 9:		Line 9:
	**[[Ceftriaxone]] 1g IV q24hrs		**[[Ceftriaxone]] 1g IV q24hrs

	====Complicated====		====Complicated or Healthcare Associated====
	''Examples of complication include severe [[sepsis]] or hemodynamic instability''		''Examples of complication include severe [[sepsis]] or hemodynamic instability''
	*[[Vancomycin]] 15-20mg/kg PLUS any of the following options		*[[Vancomycin]] 15-20mg/kg PLUS any of the following options

Rossdonaldson1: /* Complicated */

2019-04-03T02:46:16Z

Complicated

← Older revision		Revision as of 02:46, 3 April 2019
Line 10:		Line 10:

	====Complicated====		====Complicated====
	''~~Complicated disease such as~~ severe sepsis or hemodynamic instability''		''Examples of complication include severe [[sepsis]] or hemodynamic instability''
	*[[Vancomycin]] 15-20mg/kg PLUS any of the following options		*[[Vancomycin]] 15-20mg/kg PLUS any of the following options
	'''Options:'''		'''Options:'''

Rossdonaldson1 at 02:45, 3 April 2019

2019-04-03T02:45:37Z

← Older revision		Revision as of 02:45, 3 April 2019
Line 1:		Line 1:
	''Most often isolated organisms are [[Escherichia coli]], [[Klebsiella pneumonia]], and [[anaerobes]], especially [[Bacteroides fragilis]]~~; pathogenicity of [[Enterococci]] remains unclear and specific coverage is not routinely suggested for community-acquired infections~~''~~<ref>Ansaloni L, et al. 2016 WSES guidelines on acute calculous cholecystitis. World Journal of Surgery. (2016) 11:25. DOI 10.1186/s13017-016-0082-5</ref>~~		''Most often isolated organisms are [[Escherichia coli]], [[Klebsiella pneumonia]], and [[anaerobes]], especially [[Bacteroides fragilis]]''

	====Uncomplicated Cholecystitis====		====Uncomplicated Cholecystitis====
			''Pathogenicity of [[Enterococci]] remains unclear and specific coverage is not routinely suggested for community-acquired infections''<ref>Ansaloni L, et al. 2016 WSES guidelines on acute calculous cholecystitis. World Journal of Surgery. (2016) 11:25. DOI 10.1186/s13017-016-0082-5</ref>
	*[[Ertapenem]] 1g IV once daily OR		*[[Ertapenem]] 1g IV once daily OR
	*[[Metronidazole]] 500mg IV q8hrs PLUS		*[[Metronidazole]] 500mg IV q8hrs PLUS

Rossdonaldson1 at 02:33, 3 April 2019

2019-04-03T02:33:02Z

← Older revision		Revision as of 02:33, 3 April 2019
Line 1:		Line 1:
	''Most often isolated organisms are [[Escherichia coli]], [[Klebsiella pneumonia]], and [[anaerobes]], especially [[Bacteroides fragilis]]; pathogenicity of [[Enterococci]] remains unclear and specific coverage is not routinely suggested for community-acquired infections''		''Most often isolated organisms are [[Escherichia coli]], [[Klebsiella pneumonia]], and [[anaerobes]], especially [[Bacteroides fragilis]]; pathogenicity of [[Enterococci]] remains unclear and specific coverage is not routinely suggested for community-acquired infections''<ref>Ansaloni L, et al. 2016 WSES guidelines on acute calculous cholecystitis. World Journal of Surgery. (2016) 11:25. DOI 10.1186/s13017-016-0082-5</ref>

	====Uncomplicated Cholecystitis====		====Uncomplicated Cholecystitis====

← Older revision		Revision as of 13:20, 20 March 2026
Line 19:		Line 19:
	*{{AntibioticDose\|disease=Acute calculous cholecystitis\|drug=Doripenem\|dose=500mg IV q8hrs\|context=Complicated}}		*{{AntibioticDose\|disease=Acute calculous cholecystitis\|drug=Doripenem\|dose=500mg IV q8hrs\|context=Complicated}}
	*{{AntibioticDose\|disease=Acute calculous cholecystitis\|drug=Meropenem\|dose=1g IV q8hrs\|context=Complicated}}		*{{AntibioticDose\|disease=Acute calculous cholecystitis\|drug=Meropenem\|dose=1g IV q8hrs\|context=Complicated}}

			====Pediatric====
			*{{AntibioticDose\|disease=Acute calculous cholecystitis\|drug=Ceftriaxone\|dose=50-75mg/kg IV daily (max 2g)\|context=Pediatric\|population=Pediatric}} + {{AntibioticDose\|disease=Acute calculous cholecystitis\|drug=Metronidazole\|dose=7.5mg/kg IV q8hrs (max 500mg)\|context=Pediatric\|population=Pediatric}} '''OR'''
			*{{AntibioticDose\|disease=Acute calculous cholecystitis\|drug=Piperacillin/Tazobactam\|dose=80-100mg/kg IV q6-8hrs (max 4.5g)\|context=Pediatric\|population=Pediatric}} '''OR'''
			*{{AntibioticDose\|disease=Acute calculous cholecystitis\|drug=Meropenem\|dose=20mg/kg IV q8hrs (max 1g)\|context=Pediatric Complicated\|population=Pediatric}}

← Older revision		Revision as of 23:13, 19 March 2026
Line 3:		Line 3:
	====Uncomplicated====		====Uncomplicated====
	''Pathogenicity of [[Enterococci]] remains unclear and specific coverage is not routinely suggested for community-acquired infections''<ref name="WSES 2016">Ansaloni L, et al. 2016 WSES guidelines on acute calculous cholecystitis. World Journal of Surgery. (2016) 11:25. DOI 10.1186/s13017-016-0082-5</ref>		''Pathogenicity of [[Enterococci]] remains unclear and specific coverage is not routinely suggested for community-acquired infections''<ref name="WSES 2016">Ansaloni L, et al. 2016 WSES guidelines on acute calculous cholecystitis. World Journal of Surgery. (2016) 11:25. DOI 10.1186/s13017-016-0082-5</ref>
	*{{AntibioticDose\|disease=~~Cholecystitis~~\|drug=Ertapenem\|dose=1g IV once daily\|context=Uncomplicated}} OR		*{{AntibioticDose\|disease=Acute calculous cholecystitis\|drug=Ertapenem\|dose=1g IV once daily\|context=Uncomplicated}} OR
	*{{AntibioticDose\|disease=~~Cholecystitis~~\|drug=Metronidazole\|dose=500mg IV q8hrs\|context=Uncomplicated}} PLUS		*{{AntibioticDose\|disease=Acute calculous cholecystitis\|drug=Metronidazole\|dose=500mg IV q8hrs\|context=Uncomplicated}} PLUS
	**{{AntibioticDose\|disease=~~Cholecystitis~~\|drug=Ciprofloxacin\|dose=400mg IV q12 hrs\|context=Uncomplicated}} OR		**{{AntibioticDose\|disease=Acute calculous cholecystitis\|drug=Ciprofloxacin\|dose=400mg IV q12 hrs\|context=Uncomplicated}} OR
	**{{AntibioticDose\|disease=~~Cholecystitis~~\|drug=Levofloxacin\|dose=750mg IV q24hrs\|context=Uncomplicated}} OR		**{{AntibioticDose\|disease=Acute calculous cholecystitis\|drug=Levofloxacin\|dose=750mg IV q24hrs\|context=Uncomplicated}} OR
	**{{AntibioticDose\|disease=~~Cholecystitis~~\|drug=Ceftriaxone\|dose=1g IV q24hrs\|context=Uncomplicated}}		**{{AntibioticDose\|disease=Acute calculous cholecystitis\|drug=Ceftriaxone\|dose=1g IV q24hrs\|context=Uncomplicated}}

	====Complicated or Healthcare Associated====		====Complicated or Healthcare Associated====
	''Examples of complication include severe [[sepsis]] or hemodynamic instability''		''Examples of complication include severe [[sepsis]] or hemodynamic instability''
	*{{AntibioticDose\|disease=~~Cholecystitis~~\|drug=Vancomycin\|dose=15-20mg/kg\|context=Complicated/Healthcare Associated}} PLUS any of the following options		*{{AntibioticDose\|disease=Acute calculous cholecystitis\|drug=Vancomycin\|dose=15-20mg/kg\|context=Complicated/Healthcare Associated}} PLUS any of the following options

	'''Options:'''		'''Options:'''
	*{{AntibioticDose\|disease=~~Cholecystitis~~\|drug=Metronidazole\|dose=500mg IV q8hrs\|context=Complicated}} PLUS {{AntibioticDose\|disease=~~Cholecystitis~~\|drug=Ciprofloxacin\|dose=400mg IV q12hrs\|context=Complicated}}		*{{AntibioticDose\|disease=Acute calculous cholecystitis\|drug=Metronidazole\|dose=500mg IV q8hrs\|context=Complicated}} PLUS {{AntibioticDose\|disease=Acute calculous cholecystitis\|drug=Ciprofloxacin\|dose=400mg IV q12hrs\|context=Complicated}}
	*{{AntibioticDose\|disease=~~Cholecystitis~~\|drug=Piperacillin/Tazobactam\|dose=4.5g IV q8hrs\|context=Complicated}}		*{{AntibioticDose\|disease=Acute calculous cholecystitis\|drug=Piperacillin/Tazobactam\|dose=4.5g IV q8hrs\|context=Complicated}}
	*{{AntibioticDose\|disease=~~Cholecystitis~~\|drug=Imipenem/Cilastatin\|dose=500mg IV q6hrs\|context=Complicated}}		*{{AntibioticDose\|disease=Acute calculous cholecystitis\|drug=Imipenem/Cilastatin\|dose=500mg IV q6hrs\|context=Complicated}}
	*{{AntibioticDose\|disease=~~Cholecystitis~~\|drug=Doripenem\|dose=500mg IV q8hrs\|context=Complicated}}		*{{AntibioticDose\|disease=Acute calculous cholecystitis\|drug=Doripenem\|dose=500mg IV q8hrs\|context=Complicated}}
	*{{AntibioticDose\|disease=~~Cholecystitis~~\|drug=Meropenem\|dose=1g IV q8hrs\|context=Complicated}}		*{{AntibioticDose\|disease=Acute calculous cholecystitis\|drug=Meropenem\|dose=1g IV q8hrs\|context=Complicated}}

← Older revision		Revision as of 23:12, 19 March 2026
Line 3:		Line 3:
	====Uncomplicated====		====Uncomplicated====
	''Pathogenicity of [[Enterococci]] remains unclear and specific coverage is not routinely suggested for community-acquired infections''<ref name="WSES 2016">Ansaloni L, et al. 2016 WSES guidelines on acute calculous cholecystitis. World Journal of Surgery. (2016) 11:25. DOI 10.1186/s13017-016-0082-5</ref>		''Pathogenicity of [[Enterococci]] remains unclear and specific coverage is not routinely suggested for community-acquired infections''<ref name="WSES 2016">Ansaloni L, et al. 2016 WSES guidelines on acute calculous cholecystitis. World Journal of Surgery. (2016) 11:25. DOI 10.1186/s13017-016-0082-5</ref>
	*{{AntibioticDose\|drug=Ertapenem\|dose=1g IV once daily\|context=Uncomplicated}} OR		*{{AntibioticDose\|disease=Cholecystitis\|drug=Ertapenem\|dose=1g IV once daily\|context=Uncomplicated}} OR
	*{{AntibioticDose\|drug=Metronidazole\|dose=500mg IV q8hrs\|context=Uncomplicated}} PLUS		*{{AntibioticDose\|disease=Cholecystitis\|drug=Metronidazole\|dose=500mg IV q8hrs\|context=Uncomplicated}} PLUS
	**{{AntibioticDose\|drug=Ciprofloxacin\|dose=400mg IV q12 hrs\|context=Uncomplicated}} OR		**{{AntibioticDose\|disease=Cholecystitis\|drug=Ciprofloxacin\|dose=400mg IV q12 hrs\|context=Uncomplicated}} OR
	**{{AntibioticDose\|drug=Levofloxacin\|dose=750mg IV q24hrs\|context=Uncomplicated}} OR		**{{AntibioticDose\|disease=Cholecystitis\|drug=Levofloxacin\|dose=750mg IV q24hrs\|context=Uncomplicated}} OR
	**{{AntibioticDose\|drug=Ceftriaxone\|dose=1g IV q24hrs\|context=Uncomplicated}}		**{{AntibioticDose\|disease=Cholecystitis\|drug=Ceftriaxone\|dose=1g IV q24hrs\|context=Uncomplicated}}

	====Complicated or Healthcare Associated====		====Complicated or Healthcare Associated====
	''Examples of complication include severe [[sepsis]] or hemodynamic instability''		''Examples of complication include severe [[sepsis]] or hemodynamic instability''
	*{{AntibioticDose\|drug=Vancomycin\|dose=15-20mg/kg\|context=Complicated/Healthcare Associated}} PLUS any of the following options		*{{AntibioticDose\|disease=Cholecystitis\|drug=Vancomycin\|dose=15-20mg/kg\|context=Complicated/Healthcare Associated}} PLUS any of the following options

	'''Options:'''		'''Options:'''
	*{{AntibioticDose\|drug=Metronidazole\|dose=500mg IV q8hrs\|context=Complicated}} PLUS {{AntibioticDose\|drug=Ciprofloxacin\|dose=400mg IV q12hrs\|context=Complicated}}		*{{AntibioticDose\|disease=Cholecystitis\|drug=Metronidazole\|dose=500mg IV q8hrs\|context=Complicated}} PLUS {{AntibioticDose\|disease=Cholecystitis\|drug=Ciprofloxacin\|dose=400mg IV q12hrs\|context=Complicated}}
	*{{AntibioticDose\|drug=Piperacillin/Tazobactam\|dose=4.5g IV q8hrs\|context=Complicated}}		*{{AntibioticDose\|disease=Cholecystitis\|drug=Piperacillin/Tazobactam\|dose=4.5g IV q8hrs\|context=Complicated}}
	*{{AntibioticDose\|drug=Imipenem/Cilastatin\|dose=500mg IV q6hrs\|context=Complicated}}		*{{AntibioticDose\|disease=Cholecystitis\|drug=Imipenem/Cilastatin\|dose=500mg IV q6hrs\|context=Complicated}}
	*{{AntibioticDose\|drug=Doripenem\|dose=500mg IV q8hrs\|context=Complicated}}		*{{AntibioticDose\|disease=Cholecystitis\|drug=Doripenem\|dose=500mg IV q8hrs\|context=Complicated}}
	*{{AntibioticDose\|drug=Meropenem\|dose=1g IV q8hrs\|context=Complicated}}		*{{AntibioticDose\|disease=Cholecystitis\|drug=Meropenem\|dose=1g IV q8hrs\|context=Complicated}}